Fosun Pharma-backed Check-Cap has received $12m in an initial public offering and an additional $12m in a private placement.
Check-Cap, an Israel-based medical diagnostics company backed by Shanghai Fosun Pharmaceutical Group and conglomerate General Electric, closed a $12m initial public offering on Tuesday, alongside a $12m private placement.
Both the IPO, which took place on Nasdaq, and the private placement consisted of 2 million shares priced at $6 each. Chardan Capital Markets and Maxim Group served as joint book-runners.
Check-Cap is developing a disposable, ingestible imaging capsule that uses low-dose X-rays to create a 3D image of a patient’s…
